General Probiotics develops innovative cellbots, antimicrobial probiotics that eliminate harmful pathogens in livestock.
General Probiotics (GP) is a biotechnology company that discovers, develops and commercializes a new class of antimicrobial medicines for infectious diseases.GP engineers are world leaders in advanced probiotics. GP probiotics are tailored to eliminate pathogens effectively and reliably.GP has been awarded Small Business Innovative Research grants by the US National Science Foundation and the US Department of Agriculture to pursue an unparalleled, AI-enabled R&D program.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 2, 2020 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Aug 30, 2017 | Grant | $0.90M | 1 | National Science Foundation | — | Detail |
Jun 20, 2016 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |